Key facts
- This page summarizes Steve E. Krognes's Form 4 filing for Guardant Health, Inc. (GH).
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 11 Aug 2022, 16:12.
Steve E. Krognes - 09 Aug 2022 Form 4 Insider Report for Guardant Health, Inc. (GH)
- Reporting relationship
- Director
- Issuer ticker
- GH
- Reported as of
- 09 Aug 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 11 Aug 2022, 16:12:14 UTC
- Prior SEC filing
- 21 Jul 2022
- Next SEC filing
- 23 Aug 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ John Saia, as attorney-in-fact for Steve Krognes
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Steve E. Krognes filed Form 4 for Guardant Health, Inc. (GH) on 11 Aug 2022.
Change
- Previous filing in this sequence was filed on 21 Jul 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
GH
transaction
Derivative
RESTRICTED STOCK UNITS
Award
- Transaction value
- $0
- Shares
- +7,405
- Change %
- Price
- $0.000000
- Shares after
- 7,405
- Date
- 09 Aug 2022
- Ownership
- Direct
- Underlying class
- COMMON STOCK
- Underlying amount
- 7,405
- Exercise price
- $0.000000
- Footnotes
- F1, F2
GH
transaction
Derivative
STOCK OPTION (RIGHT TO BUY)
Award
- Transaction value
- $0
- Shares
- +11,879
- Change %
- Price
- $0.000000
- Shares after
- 11,879
- Date
- 09 Aug 2022
- Ownership
- Direct
- Underlying class
- COMMON STOCK
- Underlying amount
- 11,879
- Exercise price
- $48.96
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
The restricted stock unit vests as to 25% of the shares subject to such award on August 9, 2023, and as to the remaining 75% of the shares subject to such award in substantially equal installments on each monthly anniversary of August 9, 2023, during the three-year period thereafter.
Footnote F2
Not applicable for Restricted Stock Units.
Footnote F3
The stock option vest as to 25% of the shares subject to such award on August 9, 2023, and as to the remaining 75% of the shares subject to such award in substantially equal installments on eachmonthly anniversary of August 9, 2023, during the three-year period thereafter.